← All stocks

ADIAL PHARMACEUTICALS, INC.

ADIL Net buying
CIK 0001513525 #5135 in the set updated 18 Sep 2026
Bought (12 mo)
$106.33K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$106.33K
+$106.33K against sales at will

By person

7 insiders · 5 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Coastlands Capital LP entity
10% owner
$106.33K (5)
+$106.33K
388,308
$1.07M
+11.5%
Davidson Matt
Chief Development Officer
300,918
$827.52K
+19,914%
Claiborne Cary J
Chief Executive Officer
40,417
$111.15K
+1,562%
Goodman Tony
Chief Operating Officer
26,523
$72.94K
+203,923%
Shah Vinay
Chief Financial Officer
17,325
$47.64K
Schuyler Kevin
Director
9,213
$25.34K
+32,804%
Gilliland Robertson H.
Director
9,185
$25.26K

No percentages here. This company's share count has moved by a factor of 16.8 over the window, from 1,427,970 to 23,987,587 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 11
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 399,604
History held since 2 Aug 2018